Key result
Tyrosine kinase inhibitor discontinuation and reinitiation patterns in US patients with chronic myeloid leukemia were characterized using real-world data.
Why the study?
Despite survival improvements with tyrosine kinase inhibitors, overall survival among chronic myeloid leukemia patients in the US remains lower than expected.
What are the real-world patterns of tyrosine kinase inhibitor discontinuation and reinitiation among CML patients in the US?
What are the real-world patterns of tyrosine kinase inhibitor discontinuation and reinitiation among CML patients in the US?
Answers are grounded in this paper and cite their sources.
This study examines real-world patterns of TKI discontinuation and reinitiation among CML patients in the US.
Despite the significant survival improvements achieved with the introduction of tyrosine kinase inhibitors (TKIs), overall survival among chronic myeloid leukemia (CML) patients in the US remains l...
No takes yet. Share an insight, caveat, or question.
Sarker et al. (2025) studied this question. Tyrosine kinase inhibitor discontinuation and reinitiation patterns in US patients with chronic myeloid leukemia were characterized using real-world data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: